Lance Kurata serves as the Chief Legal Officer at Arcturus Therapeutics Holdings Inc., a leading biotechnology company focused on developing innovative RNA therapeutics. In his role, Kurata is responsible for overseeing all legal aspects of the company, including intellectual property management, corporate governance, and compliance with regulatory requirements. His strategic guidance has been instrumental in navigating the complex landscape of the biotech industry, ensuring that Arcturus remains at the forefront of RNA technology development. Before joining Arcturus, Kurata built an impressive career in the legal field, with a strong focus on life sciences and intellectual property law. He earned his Juris Doctor degree from a top-tier law school and began his career at a prominent law firm, where he quickly gained recognition for his expertise in biotechnology and pharmaceuticals. Kurata's deep understanding of the industry, combined with his legal acumen, has allowed him to play a key role in numerous high-profile transactions and collaborations, further strengthening Arcturus' position in the market. Under Kurata's leadership, Arcturus has successfully navigated the challenges of bringing cutting-edge RNA therapies to market. His contributions have been vital in securing partnerships with major pharmaceutical companies and in advancing the company's pipeline of promising treatments. Kurata's dedication to the company's mission and his ability to provide sound legal counsel have made him an invaluable asset to Arcturus Therapeutics Holdings Inc. as they continue to push the boundaries of what is possible in the field of RNA medicine.